Abstract
BackgroundTourniquets used for peripheral venous vascular access such as blood sampling are regularly contaminated in clinical routine. Although most contaminations are harmless, some pose a possible risk for infection. To improve peripheral venous access infection control standards, tourniquets with no or as few as possible bacterial burden should be used. Conventional tourniquets can be reprocessed by autoclaving or by incubating in disinfectants. However, both methods are time-consuming and not suitable for immediate use between patients. In contrast, silicone tourniquets can be quickly and simply reprocessed with wipe disinfection. In vitro studies from the manufacturer have demonstrated reduced bacterial contamination on silicone tourniquets after usage compared to conventional tourniquets. This study aims to independently investigate the bacterial load on both types of tourniquets in clinical routine.MethodsIn a first trial, new conventional and silicon tourniquets were used for blood sampling in one facility with strict guidelines for reprocessing (after each patient or not at all) for 1 day and tested for bacterial contamination. In a second trial, new tourniquets were used in four facilities while the mode and frequency of tourniquets’ reprocessing was defined individually by each facility. The number of treated patients, mode and frequency of reprocessing and other relevant handling measures were documented.ResultsUnder controlled conditions, with strictly specified reprocessing, slightly fewer bacteria were found on silicone than on conventional tourniquets. In routine clinical practice the reprocessing frequency was not higher for silicone tourniquets in practice. Yet, in all four facilities, there were significantly fewer bacteria found on silicone than on conventional tourniquets.ConclusionAlthough tourniquets are classified as non-critical medical devices, results show – together with benefits of faster and easier reprocessing – that silicone tourniquets can improve infection control of venous vascular access.
Highlights
Tourniquets used for peripheral venous vascular access such as blood sampling are regularly contaminated in clinical routine
Our results indicate that silicone tourniquets provide an opportunity to improve overall infection control and thereby patient safety in venous access procedures
In the first trial, we instructed the personnel about the reprocessing procedure to get an impression of the contamination level on conventional (CT) and silicon tourniquets (ST) in routine clinical practice after 1 day of use
Summary
Tourniquets used for peripheral venous vascular access such as blood sampling are regularly contaminated in clinical routine. Conventional tourniquets can be reprocessed by autoclaving or by incubating in disinfectants. Both methods are time-consuming and not suitable for immediate use between patients. The second strategy is based on reprocessing reusable tourniquets They should be reprocessed after each patient, typically by autoclaving or incubation in disinfectants. Both procedures are time consuming and in practice reusable tourniquets are rarely processed between patients [3, 6, 16]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.